Hisun Pharmaceutical
Hisun Pharmaceutical, officially known as Zhejiang Hisun Pharmaceutical Co., Ltd., is a prominent player in the global pharmaceutical industry, headquartered in CN. Founded in 1956, the company has established a strong presence in major operational regions, including Asia, Europe, and North America. Hisun Pharmaceutical focuses on the research, development, and manufacturing of a diverse range of products, including generic drugs, active pharmaceutical ingredients (APIs), and innovative therapies. With a commitment to quality and innovation, Hisun has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. The company is recognised for its unique approach to drug development, particularly in oncology and cardiovascular treatments. Hisun Pharmaceutical continues to make strides in the industry, solidifying its reputation as a trusted provider of high-quality pharmaceutical solutions.
DitchCarbon Score
How does Hisun Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hisun Pharmaceutical's score of 22 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hisun Pharmaceutical's reported carbon emissions
Hisun Pharmaceutical, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions data. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As of now, Hisun Pharmaceutical does not inherit emissions data from any parent or related organizations, meaning all available information is self-reported. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate commitments. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from Hisun Pharmaceutical, it remains unclear how they align with these industry trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hisun Pharmaceutical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
